Beta Bionics, Inc. Net Income
Beta Bionics, Inc. (BBNX) reported Net Income of -$23.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-07-29
- Beta Bionics, Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$23.40M.
- Beta Bionics, Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$21.89M.
- Beta Bionics, Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$13.47M.
- Beta Bionics, Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$14.21M.
- Beta Bionics, Inc. net income (loss) attributable to parent for fiscal 2025 was -$73.20M.
- Beta Bionics, Inc. net income (loss) attributable to parent for fiscal 2024 was -$54.76M.
- Beta Bionics, Inc. net income (loss) attributable to parent for fiscal 2023 was -$44.10M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$23.40M 10-Q · filed 2026-07-29 | -$45.30M 10-Q · filed 2026-07-29 | -$58.76M derived: sum of 3 quarters · filed 2026-07-29 | -$72.97M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$21.89M 10-Q · filed 2026-04-21 | -$35.36M derived: sum of 2 quarters · filed 2026-04-21 | -$49.57M derived: sum of 3 quarters · filed 2026-04-21 | -$66.44M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$13.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$27.68M derived: sum of 2 quarters · filed 2026-02-24 | -$44.54M derived: sum of 3 quarters · filed 2026-07-29 | -$73.20M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$14.21M 10-Q · filed 2025-10-28 | -$31.08M derived: sum of 2 quarters · filed 2026-07-29 | -$59.73M 10-Q · filed 2025-10-28 | -$77.84M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$16.87M 10-Q · filed 2026-07-29 | -$45.52M 10-Q · filed 2026-07-29 | -$63.63M derived: sum of 3 quarters · filed 2026-07-29 | -$73.37M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$28.66M 10-Q · filed 2026-04-21 | -$46.76M derived: sum of 2 quarters · filed 2026-04-21 | -$56.50M derived: sum of 3 quarters · filed 2026-04-21 | -$70.96M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | -$18.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$27.84M derived: sum of 2 quarters · filed 2026-02-24 | -$42.31M derived: sum of 3 quarters · filed 2026-02-24 | -$54.76M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$9.74M 10-Q · filed 2025-10-28 | -$24.20M derived: sum of 2 quarters · filed 2025-10-28 | -$36.65M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | -$14.46M 10-Q · filed 2025-07-29 | -$26.91M 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | -$12.45M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | -$44.10M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |